Background {#Sec1}
==========

Rationale {#Sec2}
---------

Patients with reduced level of arousal on admission to hospital are common \[[@CR1]--[@CR5]\]. A range of scales are used to describe level of arousal; the Glasgow Coma Scale (GCS)\[[@CR6]\], AVPU (Alert, responds to Verbal stimulus, responds to Painful stimulus and Unresponsive) \[[@CR7]\], Observational Scale of Level of Arousal (OSLA) \[[@CR8]\] and the Richmond Agitation-Sedation Scale (RASS) \[[@CR9]\]. Reduced level of arousal is associated with mortality \[[@CR10]--[@CR12]\]. However, study populations and methods of assessment of level of arousal were heterogeneous.

Delirium is an acute, severe neuropsychiatric syndrome characterised by acute onset and fluctuating course, inattention and other changes in cognition, perceptual deficits, and altered level of arousal \[[@CR13]\]. Delirium can be hyperactive - associated with increased activity and agitation - or hypoactive - associated with reduced level of arousal and lack of engagement, or mixed. Delirium is associated with poor outcomes \[[@CR14]--[@CR17]\] such as increased mortality: hazard ratio one year mortality for hyperactive delirium 1.3, hypoactive 1.6 and mixed 1.25 \[[@CR18]\]. Many studies of delirium explicitly exclude people who are too drowsy to be tested \[[@CR19]\], meaning studies of delirium and mortality are more difficult to interpret. Reduced level of arousal of acute onset, in the absence of trauma, is highly specific to delirium \[[@CR4], [@CR5], [@CR8]\]. Hypoactive delirium is less likely to be recognised than cases with hyperactive features \[[@CR2], [@CR20], [@CR21]\] and has poorer outcomes \[[@CR18], [@CR21], [@CR22]\]. The majority of acute medical patients with reduced level of arousal are likely to have delirium, which may be undiagnosed, and the majority of these will be older patients. It is important to establish the association between reduced level of arousal and mortality.

Objectives {#Sec3}
----------

We conducted a systematic review to establish if reduced level of arousal on admission to hospital with acute medical conditions is associated with increased mortality in adult patients.

Methods {#Sec4}
=======

This review was reported in accordance with the Preferred Reporting of Items in Systematic Reviews and Meta-Analyses (PRISMA) guidance \[[@CR23]\].

Protocol and registration {#Sec5}
-------------------------

The protocol was prospectively registered on Prospero: [http://www.crd.york.ac.uk/PROSPERO/](http://www.crd.york.ac.uk/PROSPERO) (reference CRD42016022048).

Eligibility criteria {#Sec6}
--------------------

The pre-determined inclusion criteria were (1) adults with acute medical illnesses requiring admission to hospital, (2) patients in emergency departments, acute medical units, acute receiving units, acute geriatric units, medical assessment units or equivalent, (3) patients in whom an assessment of level of arousal was made using either (i) a validated scale (e.g. GCS, AVPU, RASS or OSLA) or (ii) a subjective description (e.g. drowsy), (4) in-hospital mortality data comparing a drowsy group with a non-drowsy or less drowsy group.

The pre-determined exclusion criteria were (1) studies including children, (2) studies excluding patients aged over 65, (3) studies solely in intensive care units, (4) patients with a surgical condition given these patients may have undergone trauma, or early surgery and thus have exposure to anaesthetic agents, (5) studies solely including patients with direct central nervous system injuries: trauma, stroke, brain abscess, brain tumour, meningitis and encephalitis, (6) patients with poisoning, post drowning or post cardiac arrest. The protocol was altered to exclude patients with epilepsy and tropical diseases. Neither condition are typical of reduced level of arousal associated with general medical illness. If studies had a mixed population where less than half of the population had excluded conditions, these studies were included to reflect the case mix seen in general medical wards.

Data sources {#Sec7}
------------

An inclusive search strategy was developed with an experienced librarian. The following data sources were searched in January 2016, and the search updated in June 2017: (1) Ovid MEDLINE (R) 1946 to present with daily update, (2) Ovid MEDLINE (R) In-process and other non-indexed citations, (3) Embase (1974 onwards) (Additional file [1](#MOESM1){ref-type="media"}: Appendix 1). We asked experts from the European Delirium Association and American Delirium Society to identify any additional references. The grey literature was not searched. We searched for articles in all languages and non-expertly translated potentially relevant abstracts where possible. We performed forward citation searches of included articles and checked reference lists of review articles.

Data Collection {#Sec8}
---------------

Two reviewers (AT, SB) independently reviewed all titles and abstracts for eligibility. They then independently evaluated full texts for inclusion, resolving any disagreement by discussion. Data extracted by each reviewer comprised: type of study, condition studied, age range with descriptive statistics setting, sample size, prevalence of drowsiness, arousal scale used to evaluate drowsiness and the definition used, descriptive terms used to describe level of arousal, in-hospital mortality in the two groups, any adjustments made to the analysis and the conclusion of the study. We primarily sought odds ratios (OR) for mortality. If these were not presented in the study, but the raw data were available, we calculated OR. Where there was ambiguity over results we contacted authors to clarify.

Risk of Bias Assessment {#Sec9}
-----------------------

Risk of bias for each study was assessed using a modified version of the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS) \[[@CR24]\] (Additional file [1](#MOESM1){ref-type="media"}: Appendix 2).

Synthesis of Results {#Sec10}
--------------------

We performed quantitative analysis using Review Manager (RevMan) \[[@CR25]\]. Dichotomous data were analysed using a random effects model to calculate a pooled OR with 95% confidence interval (CI). Statistical heterogeneity was quantified using I^2^ and supplemented by evaluation of the clinical heterogeneity and inspection of the forest plot. A sensitivity analysis was performed including only those studies which used the Glasgow Coma Scale to evaluate level of arousal.

Results {#Sec11}
=======

Study selection {#Sec12}
---------------

We identified 21,104 references, from which we sought 133 full texts in the initial search and 2837 references from which we sought 12 full texts in June 2017 (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1PRISMA flow chart of study selection

Study characteristics {#Sec13}
---------------------

The review included 21 studies, eight of which comprised unselected medical admissions \[[@CR4], [@CR10]--[@CR12], [@CR26]--[@CR29]\] and 13 which considered specific medical conditions \[[@CR30]--[@CR42]\]. All were cohort studies; 11 prospective and 10 retrospective. The 21 studies were published between 1990 and 2017 from Europe, Africa, North America, South America and Asia (Table [1](#Tab1){ref-type="table"}). The sample size varied from 23 to 30,405 (median 469), with a total of 51,921 patients included in the review population. Mean ages ranged from 33.4 to 83.8 years. In studies with specific medical conditions the majority was respiratory (*n*=7), followed by endocrine (*n*=3), vasculitis (*n*=1), cardiology (*n*=1) and gastrointestinal (*n*=1). Several different scales were used to assess level of arousal: ten studies used GCS, two used AVPU, three used the Japan Coma Scale, one used the Kelly-Matthay scale and one used the Richmond Agitation and Sedation Scale (Additional file [1](#MOESM1){ref-type="media"}: Appendix 3). Three studies defined their own categories to describe level of arousal. Calle *et al* \[[@CR34]\] described, but did not define, 'altered level of consciousness', however the paper made clear that these were patients with reduced level of arousal, rather than agitation. Eight studies did not present the proportion of patients with reduced level of arousal; in the remaining 13 studies the prevalence ranged from 3.1%-76.9% (median 13.5%). Mortality rates ranged widely, from 1.7%-58% (median 15.9%).Table 1Descriptive information from included studies of reduced level of arousal and mortalityAuthor and countryYearStudy typeUnselected medical/ disease specificMean age (SD)Total NReduced Level of arousal n (%)Total deaths n (%)Arousal scale/ description*Prospective studies using an arousal scale with unselected patients* Aslaner et al Turkey2017Prospective cohortUnselected: ED admissions with altered mental status77 (70-83) median with IQR822632 (76.9)203 (24.7)RASS: -4 and -5 versus -3,-2 and -1 versus 0,+1,+2,+3,+4 Rathour et al India2015Prospective cohortUnselected: admissions with sepsis50.5 (16.3)20046 (23)116 (58)GCS: ≤9 versus \>9 Navinan et al Sri Lanka2013Prospective cohortUnselected: medical unit admissions50.7167Not given10 (6.0)GCS: mean Francia et al Spain2009Prospective cohortUnselected: admissions to medicine ward73.6 (16.8)500Not given65 (13)GCS: mean Burch et al S. Africa2008Prospective cohortUnselected: medical admissions from ED45.4 (17.0)469Not given113 (24.1)AVPU: A versus VPU Duckitt et al England2007Prospective cohortUnselected: medical admissions to an emergency unit72.4 (range 17-106)4286Not given355 (8.3)AVPU: A versus VPU*Prospective studies using an arousal scale with specific medical conditions* Nicolini et al Italy2014Prospective cohortRespiratory: COPD77.1207Not presented33 (15.9)Kelly Matthay Scale: From (1) alert to (6) comatose Otieno et al Kenya2010Prospective cohortEndocrine: Diabetic ketoacidosis33.4 (15.2)4728 (59.6) (11 = GCS 9-12, 17 = GCS 3-6)14 (29.8)GCS: 13-15 versus 9-12 (drowsy) versus 3-8 (coma/ obtunded) Dutta et al India2008Prospective cohortEndocrine: Myxoedema coma59.5 (14.8)23Not presented12 (52.2)GCS: mean Delahaye et al France2007Prospective cohortCardiology: Infective endocarditis59 (16.8)559Not presented95 (17)GCS: 9-15 versus 3-8*Prospective studies not using an arousal scale for specific medical conditions* Calle et al Spain2014Prospective cohortRespiratory: Community acquired pneumonia85.4 (6.4)45661 (13.5)110 (24.2)'altered level of consciousness'*Retrospective studies using an arousal scale with unselected patients* Barfod et al Denmark2012Prospective cohort^b^Unselected: admissions from EDNot given6279197 ( 3.1)107 (1.7)GCS: ≤ 13 versus \>13 Myint et al England2011Prospective cohort^a^Unselected: medical nursing home admissions83.8 (8.4)316Not given78 (24.7)GCS: cut-offs not presented*Retrospective studies using an arousal scale for specific medical conditions* Sakamoto et al Japan2017Retrospective cohortRespiratory: COPD76 (8.9)3064393 (12.8)209 (6.8)JCS: alert, dull, somnolent, coma Kaya et al Turkey2016Retrospective cohortGastrointestinal bleeding62 (25)60021 (3.5)38 (6.3)GCS: 15 versus \<15 Hasegawa et al Japan2015Retrospective cohortVasculitis: Churg Strauss61.9 (15.6)219596 (4.4)97 (4.4)JCS: alert versus non alert Yamauchi et al Japan2015Retrospective cohortRespiratory: Asthma/COPD/asthma-COPD mix68.9 (14)304052771 (9.1)794 (2.6)JCS: alert, dull, somnolent, coma. Chih-Hsun et al Taiwan2001Retrospective cohortEndocrine: Hyperglycaemic, hyperosmolar non-ketotic state67.8 (11.7)11989 (74.8) (54 GCS 9-14, 38 GCS 3-8)29 (24.4)GCS: mean*Retrospective studies not using an arousal scale for specific medical conditions* Conte et al USA1999Retrospective cohortRespiratory: Community acquired pneumoniaNot given, all over 65100080 (8)87 (8.7)Eye opening: spontaneous versus not. Verbal: orientated versus not. Motor: to voice versus not Onadeko et al Kuwait2005Retrospective cohortRespiratory: COPD63.7 (12.6)7418 (24.3)14 (18.9)Descriptive terms: 'drowsy' versus 'alert' Zweig et al USA1990Retrospective cohortRespiratory: Pneumonia80 (no SD)13365 (48.9) non-alert21 (15.8)Categories: alert, confused, arousable, comatose^a^paper stated both prospective and retrospective- prospective data collection but reviewed the information retrospectively^b^paper stated prospective, but we considered it to be retrospective as it extracted data from a previously populated databaseLevel of arousal: Level of Arousal*JCS* Japan Coma Scale

Risk of bias {#Sec14}
------------

Risk of bias was generally high for the consideration of confounding variables (Fig. [2](#Fig2){ref-type="fig"}), with a lack of sufficient information in individual studies regarding features such as the presence of dementia, use of sedative drugs, psychoactive drugs or alcohol, or inclusion of these features in multivariate analyses. The risk of confounding bias was only deemed low in one study \[[@CR40]\], which considered both dementia and psychoactive medication use. Selection of patients and incomplete data outcome were variable (Additional file [1](#MOESM1){ref-type="media"}: Appendix 4). Most studies used a known scale to measure level of arousal, therefore the risk of bias from measurement of exposure was low, although training in using the scales was not reported. None of the studies had published a protocol, therefore the risk of selective outcome reporting was unknown.Fig. 2Forest plot of association between level of arousal and mortality

Quantitative results {#Sec15}
--------------------

A wide range of scales were used to assess level of arousal. Different cut-offs were used to define the categories of drowsy and non-drowsy/less drowsy making direct comparison impossible across included studies. Multivariate analysis was performed on 16 of the studies; however, the potential confounding factors included in the analysis varied greatly (Additional file [1](#MOESM1){ref-type="media"}: Appendix 5). Raw data was available for 12 studies and two authors \[[@CR12], [@CR33]\] provided raw data to allow inclusion in meta-analysis.

Reduced level of arousal was associated with increased inpatient mortality (pooled OR 5.71 95% CI 4.21-7.74; 21,198 patients, low quality evidence: risk of bias, clinical heterogeneity, risk of publication bias). There is significant heterogeneity with an I^2^ of 64%. This can be explained by the variation in medical conditions studied and range of scales used. Two further studies\[[@CR29], [@CR36]\] reported the association between reduced level of arousal and mortality as: OR 5.10 95% CI 3.10-8.39, OR 5.65 95% CI 3.35-9.53, event rates were not available so these data could not be pooled.

Sensitivity analysis including only those studies using GCS confirmed the direction of the observed effect with a pooled OR of 9.16 (95% CI 6.37-13.18; 7,381 patients, low quality evidence due to risk of bias and clinical heterogeneity).

Data from a further five studies could not be pooled as there was insufficient data available to calculate a univariate OR \[[@CR11], [@CR26], [@CR28], [@CR30], [@CR37]\]. In patients with COPD survivors had a lower mean score (2) using the Kelly Matthay Scale \[[@CR30]\] (see Additional file [1](#MOESM1){ref-type="media"}: Appendix 3) than those who died. Nursing home patients with medical admissions\[[@CR28]\] reported "GCS at the time of admission was significantly associated with in-patient death": OR 0.877 (99% CI 0.792-0.970), that is, higher GCS was associated with reduced mortality. On multivariate analysis the hazard ratio for survival for 'low GCS' was 0.924 (99% CI 0.880-0.970). Mean GCS levels were 11.8 (+/-3.2) in survivors with hyperglycaemic, hyperosmolar non-ketotic states \[[@CR37]\] versus 7.7 (+/-4.3) for those who died in-hospital (95% CI of the difference -5.8 to -2.3). On multiple logistic regression low GCS on admission was the only factor contributing to death (OR 14.012 *p*\<0.001 (no CI given)). A cohort of unselected patients\[11\]found mean GCS of 14 (+/-2) in survivors and 13 (+/-3) in non-survivors. On multivariate analysis GCS was reportedly an independent predictor of mortality: OR 0.883 (95% CI 0.790-0.988) which was the OR of higher GCS and mortality. A preliminary study looking at early warning scores (EWS) \[[@CR26]\] showed mean GCS was 13.1 in those who died versus 14.8 in survivors, *p*=0.2330. No multivariate analyses were performed. This was the only study which did not find a statistically significant association between reduced level of arousal and in-hospital mortality. It was however small (*n*=167) with only ten deaths and the risk of bias was either high or unclear in all categories.

Risk of bias across studies {#Sec16}
---------------------------

The funnel plot (Additional file [1](#MOESM1){ref-type="media"}: Appendix 6) suggests that there may be publication bias against negative small studies.

Discussion {#Sec17}
==========

Summary of findings {#Sec18}
-------------------

This systematic review and meta-analysis demonstrates that acute medical patients with reduced level of arousal on admission to hospital have a substantially higher risk of mortality compared with those with normal or heightened level of arousal. The meta-analysis, performed using 14 of the 21 studies, found reduced level of arousal was associated with a 5.7-fold increased risk of in-hospital mortality. We felt it was important to perform a meta-analysis on these studies to confirm the underlying effect size. Sensitivity analysis including only those studies using GCS- the most widely used clinical arousal test, which has been in use without change for several decades- confirmed the direction of the observed effect with a pooled OR of 9.16. This was performed to reduce the degree of heterogeneity but note significant clinical heterogeneity remains. Studies not included in the meta-analysis showed results in the same direction, but some upper confidence intervals were close to one, suggesting some overlap between the group. This occurred in three studies. These studies were generally small and used different cut-offs to determine low and high GCS. Meta-regression was not performed due to heterogeneity of studies.

These findings have important caveats in that the included studies were heterogeneous in the populations studied and methods used to measure level of arousal. Although overall we considered the available evidence to be of low quality the consistency between studies in demonstrating a positive association between reduced level of arousal and mortality and the narrow CI for the pooled data is notable.

Delirium is also associated with increased mortality \[[@CR15]--[@CR18]\] and the majority of patients with acute-onset reduced level of arousal meet criteria for delirium \[[@CR4], [@CR5], [@CR8], [@CR13]\]. Additionally, some delirium studies exclude patients with severely reduced level of arousal \[[@CR19]\]; this restricted spectrum may have led to underestimation of the relationship between delirium diagnosis and mortality.

The 5.7-fold mortality rate can be compared with other illness severity indicators: for example raised lactate (\>4 mmol/L) on admission to hospital has an OR for in hospital mortality of four (95% CI 1.7-14.1) \[[@CR43]--[@CR45]\] and hypotension \<100mmHg has an OR of 2.0 (95% CI 1.3-2.8) \[[@CR46]\] and \<90mmHg OR 3.88 (95% CI 2.62-5.75) \[[@CR47]\].

Strengths of the review {#Sec19}
-----------------------

This was a large and comprehensive systematic review evaluating over 23,000 references using an inclusive search strategy. All references, abstracts and full texts were assessed by two independent reviewers. We translated articles as able, followed up conference abstracts and performed forward citation searches. We contacted authors for data and clarification. In light of predicted significant heterogeneity, a random effects model was used in the meta-analysis.

Limitations of the review {#Sec20}
-------------------------

It is possible that relevant studies could have been missed. We did not include non-published studies or the grey literature. We were able to translate five non-English studies but there remained nine we could not translate. No full text was available for 28 abstracts; mainly conference abstracts. We searched for future publication of full text for these articles but none were identified. Not all studies presented the data required to calculate OR but available data was increased following correspondence with study authors. Another three study authors attempted to retrieve their raw data but were unable. The available evidence from the studies included in this review was considered of low quality overall, due to the risk of bias, clinical heterogeneity and the risk of publication bias. However, similar results were found if studies that were retrospective and/or used no validated arousal scale, were removed.

Interpretation and implications for clinical practice and further research {#Sec21}
--------------------------------------------------------------------------

No previous systematic review has explored the relationship between reduced level of arousal and mortality. We were unable to explore the reasons underpinning this association. It is possible that patients with reduced level of arousal had more severe illness, however, multivariate analyses suggest reduced level of arousal is still associated with increased mortality after correcting for vital signs, and thus this is unlikely to be the sole explanation. It is plausible that reduced level of arousal contributes causally to poor outcomes, through increased risk of aspiration pneumonia, increased practical challenges of providing medical care, and impairing the ability to undergo rehabilitation.

The poor prognosis of delirium is increasingly recognised \[[@CR14]--[@CR17]\]. The majority of studies did not present sufficient information to allow us to comment on the presence of delirium, but it is established that acute-onset reduced level of arousal, in non-comatose patients, is a highly specific indicator of delirium \[[@CR4], [@CR5], [@CR8], [@CR13]\]. Only two \[[@CR4], [@CR34]\] of the included studies looked for delirium amongst their patients. Many studies of delirium specifically exclude patients with reduced level of arousal \[[@CR19]\]. Given the 5.7-fold increased risk of in-hospital mortality in this group clinicians need to be vigilant regarding these patients, consider discussion around prognosis with patients and families, and actively seek evidence to diagnose delirium and manage it appropriately.

Future research should examine the outcomes of both reduced level of arousal and delirium, considering likely aetiologies and causes of death. This would require prospective cohort studies evaluating sufficient numbers of patients, including those with primary neurological disease and/or surgical conditions for predetermined sub-group analyses. Validated level of arousal scales should be used rather than descriptive terms. Comprehensive characterisation of patient demographics, co-morbidities including dementia, drugs (particularly use of psychoactive or sedative drugs) and alcohol use should be reported. Delirium studies should include patients who are too drowsy to undergo cognitive testing or interview. This could be achieved by using specific level of arousal assessment instruments, or by using delirium scales with embedded level of arousal measurement such as the 4 "A"s Test (4AT) \[[@CR48]\].

Conclusions {#Sec22}
===========

In this systematic review and meta-analysis, reduced level of arousal on admission to hospital with general medical illnesses is associated with a 5.7-fold increased risk of in-hospital mortality. Patients with reduced level of arousal should therefore be identified as having a high risk of in-hospital death, and their care should take this into account. As acutely reduced level of arousal is a strong indicator of delirium, patients with reduced level of arousal should be assessed for delirium, and follow a delirium management pathway if diagnosed.
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:   Alert, responds to Verbal stimulus, responds to Painful stimulus and Unresponsive

CI
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:   Chronic Obstructive Pulmonary Disease
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